Skip to main content

Table 1 Clinicopathological features of the participants (n = 92)

From: The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study

Median age(range), years

51(32–71)

Pre-surgery SCC-Ag (ng/ml)

2.49(0.31–71.75)

FIGO stage

 IB1 (%)

28(30.4%)

 IB2 (%)

10(10.9%)

 IIA1 (%)

30(32.6%)

 IIA2 (%)

24(26.1%)

Tumor size > 4 cm (%)

33(35.9%)

Stromal invasion > 1/2 depth (%)

71(77.2%)

LVSI positive (%)

54(58.7%)

Lymph node metastasis (%)

33(35.9%)

Adjuvant treatment (%)

45(48.9%)

  1. Abbreviations: SCC-Ag Squamous cell carcinoma antigen, FIGO International Federation of Gynecology and Obstetrics, LVSI Lymph-vascular space invasion